AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2020
Jan 14, 2020
34931_dirs_2020-01-14_cd013b9a-ebf0-4c7e-89e9-0f4fc4ad46ef.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CALADRIUS BIOSCIENCES, INC. (CLBS)
CIK: 0000320017
Period of Report: 2020-01-13
Reporting Person: MYERS STEVEN S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-01-13 | Restricted Stock Units | A | 18292 | $3.28 | Acquired | 75319 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 8434 | Indirect |
| Common Stock | 1954 | Indirect |
| Common Stock | 802 | Indirect |
Footnotes
F1: Represents 18,292 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 13, 2021.
F2: Includes 18,292 unvested restricted stock units.